Twist Bioscience

General Information
Business:

 

We are a leading and rapidly growing synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The core of our platform is a proprietary technology that pioneers a new method of manufacturing synthetic DNA by “writing” DNA on a silicon chip. We have combined this technology with proprietary software, scalable commercial infrastructure and an e-commerce platform to create an integrated technology platform that enables us to achieve high levels of quality, precision, automation, and manufacturing throughput at a significantly lower cost than our competitors.

Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)
Employees: 221
Founded: 2013
Contact Information
Address 455 Mission Bay Boulevard South, Suite 545, San Francisco, CA 94158, US
Phone Number (800) 719-0671
Web Address http://www.twistbioscience.com
View Prospectus: Twist Bioscience
Financial Information
Market Cap $372.5mil
Revenues $21.0 mil (last 12 months)
Net Income $-68.4 mil (last 12 months)
IPO Profile
Symbol TWST
Exchange NASDAQ
Shares (millions): 5.0
Price range $14.00 - $14.00
Est. $ Volume $70.0 mil
Manager / Joint Managers J.P. Morgan/ Cowen
CO-Managers Allen & Company/ Baird
Expected To Trade: 10/31/2018
Status: Priced
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change